A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.

Toshihiko MatsumotoYoshiyuki YamamotoMasahito KotakaToshiki MasuishiYasushi TsujiHirokazu ShojiKenro HirataTakao TsudukiAkitaka MakiyamaNaoki IzawaNaoki TakahashiMasahiro TsudaHisateru YasuiTakashi OhtaYosuke KitoSatoshi OtsuShuichi HironakaKentaro YamazakiNarikazu BokuIchinosuke HyodoKenichi YoshimuraKei Muro

Published in: Targeted oncology (2024)

jRCTs041190100.

Keyphrases

metastatic colorectal cancer
phase ii study
open label
locally advanced
age related macular degeneration
placebo controlled
rectal cancer
squamous cell carcinoma
clinical trial
study protocol
wild type